ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug San Diego, CA ACEA Biosciences today announced the completion of its Phase 1 clinical study of AC0058, a novel irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor, which is in development for the treatment of B cell-related autoimmune diseases, including rheumatoid arthritis […]
BERGISCH GLADBACH – The new MACSprep™ PBMC Isolation Kit, human from Miltenyi Biotec allows the preparation of highly pure peripheral blood mononuclear cells (PBMCs) from human whole blood without density gradient centrifugation in only 25 min. The kit is ideal for the processing of small blood samples. Miltenyi Biotec has developed the MACSprep PBMC Isolation Kit, […]
Platform comprises Horizon’s viral, nuclease and transposon gene editing technologies for research and development Three new contract wins contributing a value of more than $2 million in 2017 with potential for long-term alliance development Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the world leader in the application of gene editing […]
Emeryville, CA – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today a pilot cell line development program with Shire. Under the program, BLI will install a Beacon™ optofluidic platform at Shire’s facility to validate the time and cost savings associated with the Beacon’s cell line development […]
The Company adds a fifth building in California to expand R&D capabilities SANTA ANA, Calif.—-Irvine Scientific, a world leader in the development and manufacture of cell culture media, today announced the expansion of its Orange County, California offices and laboratories, with the addition of a 40,000 square foot purpose-built R&D center at 17112 Armstrong Ave, […]
BERKELEY LIGHTS, INC. ANNOUNCES GLAXOSMITHKLINE’S (GSK) ADOPTION OF THE BEACON™ OPTOFLUIDIC PLATFORM
Emeryville, CA – Berkeley Lights, Inc. (BLI), a company dedicated to the development of transformational technologies for biopharmaceutical processes, announced today that it will deliver to GlaxoSmithKline a Beacon™ Optofluidic platform for cell line development. The Beacon platform innovates various processes within drug discovery and development, reducing lead times and increasing capacity by transforming currently […]
Sheffield, UK: Phasefocus provides a range of products and services based on its proprietary Ptychographic Quantitative Phase Imaging (QPI) technology to provide a wide range of analytical applications including label-free cell imaging and quantitative electron phase microscopy. Here, they report on the Light Microscopy Science Technology Platform at the Francis Crick Institute’s selection of the […]
Leaders in flow cytometry informatics collaborate to deliver comprehensive services complementing the leading software platform BURNABY, British Columbia & ASHLAND, Ore.–(BUSINESS WIRE)–FlowJo, LLC, a single-cell data informatics and data analysis company with 20 years of experience, announced a partnership with Cytapex Bioinformatics, Inc. to provide bioinformatics consulting and services in combination with the FlowJo® application. […]
HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has elected James Green, a current Board member, as the new Chairman of its Board of Directors effective June 5, 2017. Earl R. Lewis has served as Chairman since July 2013 […]
LA JOLLA–The Salk Institute’s Waitt Advanced Biophotonics Center and ZEISS announced today a global partnership to accelerate the frontiers of microscopy and imaging technologies. The Waitt Center, launched in 2011 with a landmark $20 million gift from Salk Board Chair Ted Waitt’s Waitt Foundation and supported by federal grants, serves as a state-of-the-art research hub, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
